Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor [NA]

View source ↗

Summary

A clinical trial evaluating in vitro organoid drug sensitivity-guided treatment for advanced pancreatic neuroendocrine tumor is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Advanced Pancreatic Neuroendocrine Tumor | NA | Status: RECRUITING